Food and agriculture company Calyxt, Inc. said Bayer CropScience, LP has agreed to settle a lawsuit brought by Calyxt in the Delaware Chancery Court.
“Under the settlement terms, the parties agreed that the 2013 License Agreement is terminated, that Bayer will destroy any technology, related product and confidential information covered by the License Agreement, and that Bayer will permanently abandon patent applications that are based on or include data related to the covered technology,” said Calyxt in a statement.
“This settlement confirms Bayer and its subsidiaries have no access to Calyxt technology or intellectual property.
“In December 2013, Calyxt entered into a Research and Commercial License Agreement with Bayer, pursuant to which Calyxt granted Bayer a license to certain patents for the research and commercialization of products developed with TALEN technology.
“Calyxt believes that Bayer has breached the License Agreement and, on March 12, 2018, Calyxt filed a complaint in Delaware Chancery Court requesting a declaration that the License Agreement has terminated for material breach and an order of specific performance requiring Bayer to comply with its post-termination obligations.
“The settlement has been filed in Delaware Chancery Court on May 15, 2018.”